The landscape of prostate cancer management is undergoing a significant transfor...
Bladder cancer is a grave concern, with a staggering cure rate exceeding 90% whe...
Researchers at the Autism Research Centre at Cambridge University have uncovered...
Are dogs indeed the catalyst for enhanced well-being and a more fulfilling exist...
Discover leading Sales & Marketing Intent Data Solutions for the Pharmaceutical ...
Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA ...
New research published in the European Heart Journal reveals startling insights ...
The U.S. Department of Health and Human Services (HHS) has been making significa...
The negotiated prices of 15 Medicare Part D drugs, which include several blockbu...
The metaverse hype is over, but developer Cassette Group has been working with P...
How longitudinal, closed claims data is advancing regulatory, epidemiology, and ...
Potential antitrust deregulation could foster a more favourable environment for ...
Charles River and Akron Bio have announced the integration of the latter’s CSS l...
The FDA has narrowly beaten the European Medicines Agency (EMA) to the most appr...
The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to so...
The Lonza CEO said the company is not under any pressure to exit the Capsules an...
